Kwality Pharmaceuticals logo

Kwality Pharmaceuticals results

NSE: KPLBSE: 539997Pharmaceuticals & BiotechnologySmall Cap

Last close ₹3,528.40down ₹89.90 (2.48%)BSE ₹3,531.70

Share price at the NSE close on 23 Oct 2026. Previous close ₹3,618.30.

52-week range of BSE trades to 23 Oct 2026
₹828.80Low, 11 Nov 2025₹3,866.55High, 21 Sep 2026
Market cap
₹3,661 Cr1,235th largest listed
P/E
45.2
P/B
11.0
Dividend yield
Nonein the last 12 months
ROE
27.2%
ROCE
25.0%
Debt to equity
0.40
Volume, NSE
38,71643.8% delivered

Q1 results, quarter to Jun 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.Kwality Pharmaceuticals annual results and balance sheet

Revenue
₹162 Cr+45.6% on a year ago · +3.5% on the quarter before
Operating profit
₹41 Cr+69.6% on a year ago · +5.9% on the quarter before
Net profit
₹26 Cr+114.8% on a year ago · +1.3% on the quarter before
Earnings per share
₹24.70+114.8% on a year ago · +1.4% on the quarter before
Operating margin
25.3%
Net margin
15.8%

From revenue to net profit, ₹ crore

  1. Revenue162
  2. Materials and goods−87
  3. Employee costs−15
  4. Other expenses−19
  5. Operating profit41
  6. Depreciation−5.0
  7. Other income+0.6
  8. Finance costs−2.7
  9. Profit before tax34
  10. Tax−8.4
  11. Net profit26

Kwality Pharmaceuticals results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreJun 2022Q1Filed 6 SepSep 2022Q2Filed 25 NovDec 2022Q3Filed 16 FebMar 2023Q4Filed 29 MayJun 2023Q1Filed 11 AugSep 2023Q2Filed 18 NovDec 2023Q3Filed 20 FebMar 2024Q4Filed 14 JunJun 2024Q1Filed 24 AugSep 2024Q2Filed 31 OctDec 2024Q3Filed 1 FebMar 2025Q4Filed 12 JunJun 2025Q1Filed 11 AugSep 2025Q2Filed 13 NovDec 2025Q3Filed 12 FebMar 2026Q4Filed 19 MayJun 2026Q1Filed 10 Aug
Revenue from operations7056566967707892809084116111111123157162
524041575454617163706790878693118121
Materials and goods bought3619213533344046394439615855598687
Employee costs68888889101011131213141415
Other expenses1013121513121316141617161718201719
Operating profit before depreciation1816151214151721172018262425303941
Operating margin25.7%27.8%27.1%16.7%20.5%21.9%21.4%22.7%21.7%21.9%20.7%22.4%21.7%22.8%24.3%24.7%25.3%
Depreciation and amortisation34445555455555555
Other income01010011001101111
Finance costs11222233232233233
Profit before one-off items and tax1411107781013111311191718233234
One-off items000−17000−7000000−100
Profit before tax141110−1078106111311191718223234
423−22222343554668
Tax rate24.9%20.0%27.9%–24.8%23.8%21.2%28.0%24.9%32.6%25.2%24.1%30.0%23.5%28.4%20.1%24.6%
Net profit1197−75684889141214162526
Other comprehensive income00000000000000000
Total comprehensive income1097−75685888151214162526
Net margin15.0%16.2%12.9%−10.7%8.1%9.0%9.9%4.9%10.4%9.4%10.1%12.5%10.7%12.7%13.0%16.1%15.8%
Earnings per share₹10.05₹8.52₹6.92−₹7.15₹5.17₹6.03₹7.42₹4.33₹8.06₹8.18₹8.23₹13.97₹11.50₹13.60₹15.43₹24.37₹24.70
Earnings per share in rupees, restated for later splits and bonuses.

Kwality Pharmaceuticals results by half year

Standalone: the listed company alone, without its subsidiaries. The half years to Mar 2022 in the same span that the quarters on record do not fully cover.

₹ croreSep 2021Filed 25 OctMar 2022Filed 10 Jun
Revenue from operations304152
173–
Materials and goods bought11883
Employee costs8–
Other expenses47–
Operating profit before depreciation131–
Operating margin43.1%–
Depreciation and amortisation5–
Other income12
Finance costs12
Profit before tax12636
3210
Tax rate25.3%27.2%
Net profit9426
Net margin30.9%17.1%
Earnings per share₹90.60₹25.09
Earnings per share in rupees, restated for later splits and bonuses.